Using multiple approaches from the cell to the whole organism and extensively examine the role of various neuroendocrine signaling systems (e.g., GLP-1, leptin, amylin, CCK, serotonin, glutamate, and dopamine) in peripheral and central control of food intake and body weight regulation
Sikiric P, Petek M, Rucman R, et al
insulin is usually tapered rather than dropped Combining a GLP-1 drug with an SGLT2 inhibitor is increasingly common in India when heart or kidney risk is present The hypoglycemia risk comes from insulin and sulfonylureas, not from the GLP-1 drug itself which is exactly why those doses are lowered in advance Check your sugar more often for two to four weeks after any dose change, and keep a simple written log RSSDI guidance places GLP-1 medicines with proven cardiovascular benefit at second or third line, especially for people at raised cardiac risk Ozempic, Rybelsus, Mounjaro, and Wegovy are not interchangeable, and only a doctor can say which, if any, fits your case Never start, stop, or adjust any of these medicines on your own Frequently Asked Questions Can I take GLP-1 with metformin
We would always recommend tapering the medication really gradually in order to avoid rebound effects
If not covered there are still different "exception" paths and options to consider
